Clinical Trial Readiness for the Dystroglycanopathies
NCT00313677
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of the study is to describe the early signs and symptoms of the dystroglycanopathies, and to gather information that will be required for future clinical trials.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Muscular Dystrophy
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- Any age
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Katherine Mathews
- Last updated on ClinicalTrials.gov
- July 30, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Iowa · 1
- University of Iowa, 200 Hawkins Drive · Iowa City, IA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.